TISSUESEAL

Tissue Seal was formed in 2002 by four members that have over 120 years' experience in the medical device industry. In 2002, Tissue Seal partnered with B.Braun Europe, to gain FDA regulatory clearance to bring Histoacryl Topical Skin adhesives to the US market. At that time, topical skin adhesives were considered a prescription drug and required Pre-Market Approval to commercialize the product. The process took nearly four years to gain the necessary approvals for Histoacryl Clear and Histoacryl Blue and entered commercial distribution in the US in March of 2007. Since that time, Tissue Seal has sold over 10 million ampoules of topical skin adhesive and has been used by many leading medical centers in the US... In December 2019, Tissue Seal entered into agreement with B.Braun to take over sales and distribution of their suture product portfolio. In 2020, Tissue Seal is marketing and distributing the full line of B.Braun closure products in the US out of the Tissue Seal ISO 13485..

Primary location: Romulus United States